The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Reported EBITDA up by 19% year-on-year with reported EBITDA margin at 25%
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Sun Pharma gets 8 observations from USFDA for Halol facility
25 women students to receive internship, training, and mentorship in Life Sciences segment
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Overall investment in the US facility is estimated around US$50 million
Subscribe To Our Newsletter & Stay Updated
